Directors & Officers
| Name | Title | Year Born |
|---|---|---|
| Mr. Graydon Bensler C.F.A. | CEO, CFO, Secretary & Director | 1992 |
ELAB
Elevai Labs, Inc. Common Stock
CIK
0001168061
Employees
32
Phone
866 445 4886
Fiscal year end
December
IPO
Nov 21, 2023
Address
120 Newport Center Drive, Newport Beach, CA, United States, 92660
2.60
+0.02 (+0.78%)
USD · NASDAQ
52-week range
2.52
1,491.84
Trading at 0% of the 52-week range
Market Cap
2.09M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
27.20
Div. Yield
N/A
% Institutions
3.28%
% Insiders
5.61%
1 Year
-99.8%3 Year
-100.0%10 Year
-100.0%Description
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Actions
Add an action for ELAB.US, or sign in to see your action list.
People
Shareholders
Financial Highlights
Market Cap:
$2.09M
EBITDA:
$-11.54M
Book Value:
$27.20
Earnings/Share:
$-1.73K
Profit Margin:
0.00%
Operating Margin:
-289.98%
ROA (TTM):
-32.97%
ROE (TTM):
-105.22%
Revenue (TTM):
$2.58M
Revenue/Share (TTM):
$19.08
Earnings Growth (YOY):
0.00%
Revenue Growth (YOY):
-45.80%
Valuation Metrics
Enterprise Value:
$-2.44M
Trailing P/E:
0.00
Forward P/E:
0.00
Shares Statistics
Shares Outstanding:
809.58K
Shares Float:
764.19K
% Insiders:
5.61%
% Institutions:
3.28%
Short % Float:
3.41%
Stock Price History
1 Year Price History
3 Years Price History
10 Years Price History
Max Price History
Financial Charts
Revenue, Net Income & Operating Cash Flow (Yearly)
Change % vs Prior Year
Revenue, Net Income & Operating Cash Flow (Quarterly)
Change % vs Prior Quarter
Operating Expenses (Yearly)
Operating Expenses (Quarterly)
Balance Sheet (Yearly)
Balance Sheet (Quarterly)
Assets Breakdown (Yearly)
Assets Breakdown (Quarterly)
Liabilities Breakdown (Yearly)
Liabilities Breakdown (Quarterly)
Income Statement Waterfall
Line Item
Step Type
Value
Revenue
adjust
$590.08K
Cost of Goods Sold
adjust
$-515.27K
Gross Profit
subtotal
$74.81K
SG&A
adjust
$-1.42M
R&D
adjust
$-147.01K
Other Operating Expense
adjust
$-5.88M
Operating Income
subtotal
$-7.38M
Other / Non-Operating Items
adjust
$-331.43K
Net Income
subtotal
$-7.71M
Earnings Per Share (EPS) History
Financial Ratios
📦 Raw API Data (JSON Explorer)
Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.